Insights Into Globe Life (GL) Q3: Wall Street Projections for Key Metrics

21.10.24 15:16 Uhr

Werte in diesem Artikel
Aktien

103,00 EUR 0,00 EUR 0,00%

Indizes

5.917,0 PKT 23,4 PKT 0,40%

In its upcoming report, Globe Life (GL) is predicted by Wall Street analysts to post quarterly earnings of $3.05 per share, reflecting an increase of 12.6% compared to the same period last year. Revenues are forecasted to be $1.47 billion, representing a year-over-year increase of 5.8%.The consensus EPS estimate for the quarter has been revised 0.1% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.With that in mind, let's delve into the average projections of some Globe Life metrics that are commonly tracked and projected by analysts on Wall Street.Analysts' assessment points toward 'Revenue- Total premium' reaching $1.18 billion. The estimate suggests a change of +5.4% year over year.Based on the collective assessment of analysts, 'Revenue- Net investment income' should arrive at $285.38 million. The estimate suggests a change of +6.9% year over year.Analysts forecast 'Revenue- Life premium' to reach $824.21 million. The estimate suggests a change of +4.6% year over year.It is projected by analysts that the 'Revenue- Health premium' will reach $354.32 million. The estimate indicates a year-over-year change of +7%.Analysts expect 'Insurance Underwriting Income- Health' to come in at $97.56 million. Compared to the present estimate, the company reported $96.70 million in the same quarter last year.The consensus estimate for 'Insurance Underwriting Income- Life' stands at $326.21 million. Compared to the current estimate, the company reported $300.09 million in the same quarter of the previous year.View all Key Company Metrics for Globe Life here>>>Over the past month, Globe Life shares have recorded returns of +3.3% versus the Zacks S&P 500 composite's +4.5% change. Based on its Zacks Rank #3 (Hold), GL will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Globe Life Inc. (GL): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Globe Life

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Globe Life

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Globe Life Inc